Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation

<p>Abstract</p> <p>We have recently developed a candidate HIV-1 vaccine model based on HIV-1 Pr55gag Virus-Like Particles (HIV-VLPs), produced in a baculovirus expression system and presenting a gp120 molecule from an Ugandan HIV-1 isolate of the clade A (HIV-VLP<sub>A</su...

Full description

Bibliographic Details
Main Authors:	Marincola Francesco M, Lewis George K, Tagliamonte Maria, Tornesello Maria, Wang Ena, Aricò Eleonora, Buonaguro Franco M, Buonaguro Luigi
Format:	Article
Language:	English
Published:	BMC 2005-12-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/3/1/45

Similar Items

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2022-02-01)

Baculovirus-Derived HIV-1 Virus-Like Particles (VLP) Activate Dendritic Cells and Are Cross-Presented to Induce In Vitro T-Cell Response
by: Lewis-Kamin R, et al.
Published: (2005-12-01)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
by: Visciano Maria Luisa, et al.
Published: (2012-01-01)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
by: Buonaguro FM, et al.
Published: (2009-10-01)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
by: Tornesello Maria, et al.
Published: (2007-05-01)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
by: Luigi Buonaguro, et al.
Published: (2020-05-01)

P19-11. Generation of virus-like particles expressing different HIV-1 glycoproteins for induction of broadly neutralizing antibodies
by: Buonaguro L, et al.
Published: (2009-10-01)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
by: Anna Lucia Tornesello, et al.
Published: (2020-04-01)

Structured particles for antigen presentation
by: Lewis GK, et al.
Published: (2006-12-01)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
by: Luisa Circelli, et al.
Published: (2015-07-01)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
by: Buonaguro Luigi, et al.
Published: (2010-10-01)

HPV monitoring in kidney transplanted patients
by: Buonaguro Franco M, et al.
Published: (2012-04-01)

Molecular mimicry and cancer vaccine development
by: Maria Tagliamonte, et al.
Published: (2023-04-01)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
by: Anna Lucia Tornesello, et al.
Published: (2017-08-01)

Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.
by: Valeria De Giorgi, et al.
Published: (2013-01-01)

Selecting Target Antigens for Cancer Vaccine Development
by: Luigi Buonaguro, et al.
Published: (2020-10-01)

Peptide-based vaccine for cancer therapies
by: Luigi Buonaguro, et al.
Published: (2023-08-01)

Corrigendum: Peptide-based vaccine for cancer therapies
by: Luigi Buonaguro, et al.
Published: (2023-10-01)

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
by: Maria Tagliamonte, et al.
Published: (2022-10-01)

Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
by: Noemy Starita, et al.
Published: (2018-03-01)

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
by: Andrea Cerasuolo, et al.
Published: (2020-06-01)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
by: Concetta Ragone, et al.
Published: (2022-07-01)

Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
by: Anna Lucia Tornesello, et al.
Published: (2020-06-01)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
by: Maria Lina Tornesello, et al.
Published: (2018-06-01)

Use of adjuvants for immunotherapy
by: Luisa Circelli, et al.
Published: (2017-08-01)

Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma
by: Buonaguro Luigi, et al.
Published: (2009-10-01)

HIV p24 as scaffold for presenting conformational HIV Env antigens.
by: Maria Tagliamonte, et al.
Published: (2012-01-01)

High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
by: Angela Mauriello, et al.
Published: (2019-11-01)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
by: A. Petrizzo, et al.
Published: (2018-03-01)

Human Papillomavirus and Cancers
by: Maria Lina Tornesello, et al.
Published: (2020-12-01)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
by: Angela Mauriello, et al.
Published: (2021-12-01)

Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders.
by: Annacarmen Petrizzo, et al.
Published: (2012-01-01)

Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
by: Sbreglia Costanza, et al.
Published: (2008-10-01)

Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
by: Buonaguro FM, et al.
Published: (2006-09-01)

Human papillomavirus infection and cervical neoplasia among migrant women living in Italy
by: Maria Lina eTornesello, et al.
Published: (2014-02-01)

Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy
by: Piccoli Roberto, et al.
Published: (2007-01-01)

Novel Molecular Targets for Hepatocellular Carcinoma
by: Beatrice Cavalluzzo, et al.
Published: (2021-12-01)

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
by: Luigi Buonaguro, et al.
Published: (2021-05-01)

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
by: Carmen Manolio, et al.
Published: (2022-10-01)

Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
by: Annacarmen Petrizzo, et al.
Published: (2018-10-01)